Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9914895 | Molecular and Cellular Endocrinology | 2005 | 6 Pages |
Abstract
Corticotropin-releasing factor (CRF) receptor type 1 (CRF1 receptor) mRNA levels are down-regulated by CRF via the cyclic AMP-protein kinase A (PKA) pathway. In this study, we focused on the involvement of both the mitogen-activated protein (MAP) kinase pathway and PKA in this regulation. Real-time PCR (RT-PCR) revealed that a MAP kinase, extracellular signal-regulated kinases 1/2, pathway was also involved in the down-regulation of CRF1 receptor mRNA levels by CRF in the rat anterior pituitary (AP). Down-regulation of CRF1 receptor mRNA levels was caused by a post-transcriptional system such as mRNA degradation, as incubation with CRF significantly decreased the half-life of CRF1 receptor mRNA. Furthermore, pre-treatment with a PKA inhibitor completely blocked CRF-induced CRF1 receptor mRNA destabilization, while pre-treatment with an extracellular signal-regulated kinases 1/2 inhibitor had no inhibitory effect. These results suggested that in the rat AP, down-regulation of CRF1 receptor mRNA levels is caused by mRNA degradation via PKA, but not by the MAP kinase pathway.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Takako Moriyama, Kazunori Kageyama, Yoko Kasagi, Yasumasa Iwasaki, Takeshi Nigawara, Satoru Sakihara, Toshihiro Suda,